NEWSROOM Press Releases

    254 Results

    MRM Proteomics and Biodesix Partner to Develop Precision Lung Cancer Diagnostics

    MRM Proteomics Inc. and Biodesix® have inked a partnership to create novel assays to answer clinical questions within the lung cancer continuum of care.

    Biodesix Confirms Prognostic Value of VeriStrat Testing in Phase 3 Study of Patients with Advanced Lung Cancer

    A new study published in the Oncologist demonstrates the objective prognostic value of the Biodesix VeriStrat® test in patients with non-small cell lung cancer

    Biodesix Extends Lung Franchise with Acquisition of Integrated Diagnostics

    Biodesix announced that it has acquired Integrated Diagnostics, Inc.

    Society for Advanced Bronchoscopy Meets May 20 to Address “Hot Topics in Advanced Bronchoscopy"

    The Society for Advanced Bronchoscopy (SAB) will hold its second meeting: Hot Topics in Advanced Bronchoscopy.

    Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules in New CHEST Data Publication

    Biodesix announced newly published data showing the noninvasive BDX-XL2 test could reduce the number of unnecessary biopsies carried out on patients with benign nodules

    Biodesix Presents Positive Data in Detection of Primary Immunotherapy Resistance to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer

    Biodesix presented positive data for a blood-based test with the potential to detect a non-small cell lung cancer (NSCLC) patient’s pre-treatment risk of anti-PD-1 immunotherapy resistance

    Society for Advanced Bronchoscopy Commits to Enhance Education and Practice Excellence as U.S. Demand for Bronchoscopy Procedures Increases

    Bronchoscopy professionals in the United States need greater educational and practice-building support to ensure continued delivery of high-quality care for Americans

    Biodesix Test Predicts Response to Atezolizumab in Lung Cancer

    Researchers with Biodesix and Genentech presented findings on a test designed to predict response to atezolizumab (Tecentriq®) in patients with non-small cell lung cancer (NSCLC)

    Biodesix Advances ORACLE Registry for Lung Nodule Cancer Test

    Biodesix provided an update on the Observational Registry study to evaluate the impact of BDX-XL2 on physician decision making in routine clinical use (ORACLE)

    New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions

    New data demonstrate that a blood-based proteomic test reliably assesses individual patient prognosis to inform treatment decisions.

    1 2 3 4 5 6 7 8 9